Gastric Inhibitory Polypeptide (3-42) (human) |
Katalog-Nr.GA21894 |
Gastric Inhibitory Polypeptide (3-42) (Mensch) wirkt als Glucose-abhÄngiger insulinotroper Polypeptid (GIP)-Rezeptorantagonist, der die insulinsekretierenden und metabolischen Wirkungen von GIP in vivo moderiert.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1802086-25-4
Sample solution is provided at 25 µL, 10mM.
Gastric inhibitory polypeptide (3-42) represents the major physiological degradation product of gastric inhibitory polypeptide (GIP). It is generated by proteolytic processing of GIP by dipeptidyl peptidase IV (DPP IV).
Average Rating: 5
(Based on Reviews and 10 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *